Barrington Research Upgrades ModivCare to Outperform, Announces $35 Price Target
Portfolio Pulse from Benzinga Newsdesk
Barrington Research has upgraded ModivCare (NASDAQ:MODV) from Market Perform to Outperform, with a new price target of $35.
August 09, 2024 | 9:37 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Barrington Research has upgraded ModivCare from Market Perform to Outperform, setting a new price target of $35.
The upgrade from Market Perform to Outperform and the new price target of $35 by Barrington Research is likely to positively impact ModivCare's stock price in the short term as it reflects increased confidence in the company's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100